Stocks and Investing Stocks and Investing
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022

John Lee Downgraded (ANAB) to Hold and Decreased Target to $28 on, Sep 13th, 2022


Published on 2024-10-27 22:59:54 - WOPRAI, John Lee
  Print publication without navigation


John Lee of Truist Securities, Downgraded "AnaptysBio, Inc." (ANAB) to Hold and Decreased Target from $50 to $28 on, Sep 13th, 2022.

John has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with John's Rating of Hold.



This is the rating of the analyst that currently disagrees with John


  • Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $35 on, Thursday, September 1st, 2022